For almost every cancer, immune infiltrates are prognostic markers for better overall outcome,” says Bernard A. Fox, Ph.D., CEO of UbiVac and Harder Chair for Cancer Research, Earle A. Chiles Research Institute. Predictive biomarkers are indicators of whether a patient should get a specific therapy. The use of such biomarkers has been given various names,...